Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,354 | 30,860 | 33,411 | 15,096 | 12,370 |
| Marketable Securities | 21,055 | 9,267 | 0 | 8,252 | 18,461 |
| Receivables | 2,375 | 445 | 676 | 1,027 | 990 |
| Other current assets | 1,274 | 1,274 | 1,702 | 1,702 | 0 |
| TOTAL | $41,528 | $42,140 | $35,899 | $26,315 | $34,024 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 23 |
| Other Non-Current Assets | 183 | 352 | 685 | 970 | 1,071 |
| TOTAL | $183 | $352 | $685 | $970 | $1,094 |
| Total Assets | $41,711 | $42,492 | $36,584 | $27,285 | $35,118 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,941 | 3,361 | 3,277 | 2,186 | 1,179 |
| Accrued Expenses | 9,117 | 7,603 | 6,412 | 5,529 | 2,824 |
| Other current liabilities | 540 | 540 | 540 | N/A | 1,525 |
| TOTAL | $17,848 | $14,954 | $14,249 | $10,349 | $6,804 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,324 | 16,067 | 10,599 | 11,879 | 13,103 |
| Deferred Revenues | 1,330 | 395 | 481 | 510 | 510 |
| Other Non-Current Liabilities | 52,253 | 29,302 | 5,227 | 5,283 | 9,852 |
| TOTAL | $68,437 | $46,868 | $17,424 | $18,859 | $24,779 |
| Total Liabilities | $86,285 | $61,822 | $31,673 | $29,208 | $31,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,832 | 11,831 | 11,036 | 7,586 | 7,586 |
| Common Shares | 118 | 117 | 110 | 76 | 76 |
| Retained earnings | -590,468 | -564,071 | -530,784 | -521,916 | -516,311 |
| Other shareholders' equity | 2 | -2 | 1 | 6 | 28 |
| TOTAL | $-44,574 | $-19,330 | $4,911 | $-1,923 | $3,535 |
| Total Liabilities And Equity | $41,711 | $42,492 | $36,584 | $27,285 | $35,118 |